BioCentury
ARTICLE | Distillery Therapeutics

Cancer

September 13, 2017 5:07 PM UTC

Patient sample, cell culture and mouse studies suggest immunotherapies targeting GPC2 could help treat neuroblastomas expressing the antigen. In neuroblastoma patients, high levels of GPC2 in tumor sa...

BCIQ Company Profiles

National Cancer Institute

BCIQ Target Profiles

Glypican 2 (GPC2)